The process could affect countries like Australia and New Zealand. USTR Jamieson Greer told POLITICO in July that Australia was “another country that could be a target for a Section 301 probe into drug pricing.”
-
Latest News
AI is already in the decision-making process, but where is the conversation about its use?
Nobody seems opposed to using artificial intelligence in health technology assessment. Government, industry and patients all back it, and each is already using it. Yet no single transparent discussion brings all three together to plan and assess its potential to fundamentally reform decision-making.
-
Latest News AbbVie’s top lawyer publicly makes the case against German pricing September 24, 2026
-
Latest News England's genomics chief to share NHS lessons during Australia visit September 24, 2026England's Chief Scientific Officer, Professor Dame Sue Hill, will visit Australia next month as governments work on progressing a new national genomics framework.
-
Latest News AZ to maintain breast cancer therapy on the PBS for six months despite price rise knocked back September 24, 2026"Universal and equitable access to medicines is critical to the continued health of Australians. The PBS will require appropriate funding to ensure Australians are not denied access to medicines," said AstraZeneca Australia and New Zealand Country President Dr Marie Guillet.
-
Latest News Medicines Australia seeks answers on AI in HTA process September 23, 2026The association has sought clarity on the scope of the department's AI use, the systems involved, and the safeguards applied to protected information.
-
Latest News The prevention gap and inside Sally Panton's bet on cellular health September 23, 2026In an interview with BioPharmaDispatch, Sally Panton, CEO and co-founder of Longevity Life Sciences, described a career built on a conviction in prevention and supporting well people to stay well.
-
A 'multistakeholder' reference group to shadow agreement negotiations September 23, 2026A reference group that consults multiple stakeholders alongside the industry agreement negotiations could be interpreted as a response to the demand for a voice.
-
Latest News Pfizer 'deeply disappointed' in response to PBAC refusing to move on price September 23, 2026"When the gap between registration and reimbursement stretches out over years, it is inevitable that global pricing and market conditions will evolve. This makes it difficult to sustain the pricing assumptions underpinning earlier submissions."
-
Latest News Lilly goes direct with a patient platform for its non-PBS medicines September 23, 2026Lilly Australia General Manager Manny Simons said the offering responds directly to the pressures the company faces in securing public reimbursement.
-
Latest News Given the official use of AI, a cease and desist would not be unreasonable September 22, 2026There are questions worth asking, not because AI should not be used, but because the lack of transparency is a problem. We only know this is happening because someone took the trouble to submit a Freedom of Information request.
-
Latest News If there is a productivity gain in the process, then it should be passed on September 22, 2026The health department has put generative AI into the machinery that decides which medicines Australians will fund, and it claims the benefit is doing the same work more thoroughly in the same amount of time. Not faster. Not cheaper. 'Deeper'. So what's the point if only officials benefit?
-
Latest News Who remembers the 'Vancouver' poster? We have a rerun September 22, 2026The Department of Health, Disability and Ageing has now confirmed that it is using AI in the health technology assessment process without telling sponsors or the industry. It has effectively said that we have asked ourselves if it is ok, and the answer is yes.
-
Australian Biotech Telix announces takeover of ITM to create a global radiopharmaceutical powerhouse September 21, 2026The Australian nuclear medicine company has agreed to lead a merger with ITM Isotope Technologies Munich SE, paying US$1.65 billion upfront on a cash-free, debt-free basis for a German company that supplies the raw material the entire targeted radionuclide therapy industry depends on.
-
Latest News Treasury has moved on from the PBS, but the policies built on its error have not September 21, 2026The 2026 Intergenerational Report finally concedes that medicines are the slow-growing part of health spending. The reforms justified by the opposite claim remain in place.
-
Latest News Officials are using AI to create efficiencies in the HTA evaluation process September 21, 2026The document confirms that officials use AI to support HTA committees by reading, summarising, and helping critically appraise submissions, and by drafting overviews, advice, commentaries, and minutes.
-
Latest News New AI contribution tool delivers 150 patient voices to the PBAC September 21, 2026"These results show that the technology works. It also validates our insight that Australian patients want to have their say on medicine access and welcome support to do so," said Boehringer Ingelheim Australia and New Zealand general manager Ed Hollywood.
-
Latest News If AI is enhancing input, then surely it is doing the same for output September 21, 2026"There's a revolution going on in healthcare and that produces savings as well to the economy, but importantly as well, better healthcare for Australians," Prime Minister Anthony Albanese said.
-
Latest News We have one of Australia's answers to 'MFN' and people will die as a result September 18, 2026We now have evidence of the official Australian response to a more assertive United States posture on medicine prices, and sadly, it concerns women with advanced breast cancer that has spread to their brain.
-
Latest News Is the fairest part of our medicines access system delivered overseas? September 18, 2026Australia's HTA committees deny patients a right of reply and independent review that another program guarantees. Until we adopt that standard for decisions made at home, patients may fairly conclude that fairness is only available offshore.
-
Latest News Queensland cardiac experts back a new plan to stop the second heart attack September 18, 2026A roadmap launched in Brisbane by a Queensland Cardiovascular Disease Expert Roundtable, convened by Amgen Australia, the Heart Foundation and Springfield Healthy Hearts, aims to close that gap.
Australian Biotech
-
Prescient raises $6 million to carry cancer drug PTX-100 past a key dosing decision
September 23, 2026 -
Seven Australian startups share $15.6 million to take on dementia
September 23, 2026 -
Dimerix draws $17 million from loan facility to fund kidney drug trials to completion
September 23, 2026 -
Actinogen's Alzheimer's pill nears its moment of truth as final trial patient is seen
September 23, 2026 -
Patrys doses first volunteers in trial of intravenous quetiapine for delirium
September 23, 2026
Other Health
-
Persistent fatigue could be an overlooked sign of liver disease
September 15, 2026 -
Bupa to discontinue international referrals for 'Doctors on Demand' telehealth
September 7, 2026 -
Combined monitoring of key indicators as the future of diabetes care
September 3, 2026 -
Private hospitals sustain 230,000 jobs despite $756 million loss
August 31, 2026 -
Rare autoimmune diseases impose a $1.2 billion annual burden on Australians
August 20, 2026
Latest Video
New Stories
-
AZ to maintain breast cancer therapy on the PBS for six months despite price rise knocked back
September 24, 2026 - - Latest News -
England's genomics chief to share NHS lessons during Australia visit
September 24, 2026 - - Latest News -
AbbVie’s top lawyer publicly makes the case against German pricing
September 24, 2026 - - Latest News -
AI is already in the decision-making process, but where is the conversation about its use?
September 24, 2026 - - Latest News -
Blood test for eight cancers arrives in Australia, but misses almost half of them
September 23, 2026 - -
Prescient raises $6 million to carry cancer drug PTX-100 past a key dosing decision
September 23, 2026 - - Australian Biotech -
Seven Australian startups share $15.6 million to take on dementia
September 23, 2026 - - Australian Biotech